Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Molecular Links between Inflammatory Bowel Disease and Mild Cognitive Impairment- a Narrative Review

Version 1 : Received: 30 March 2024 / Approved: 1 April 2024 / Online: 2 April 2024 (07:35:44 CEST)

How to cite: Sarb, O.F.; Porca, A.D.; Iacobescu, M.; Vlad, I.; Milaciu, M.V.; Ciumarnean, L.; Vacaras, V.; Tantau, A. Molecular Links between Inflammatory Bowel Disease and Mild Cognitive Impairment- a Narrative Review. Preprints 2024, 2024040135. https://doi.org/10.20944/preprints202404.0135.v1 Sarb, O.F.; Porca, A.D.; Iacobescu, M.; Vlad, I.; Milaciu, M.V.; Ciumarnean, L.; Vacaras, V.; Tantau, A. Molecular Links between Inflammatory Bowel Disease and Mild Cognitive Impairment- a Narrative Review. Preprints 2024, 2024040135. https://doi.org/10.20944/preprints202404.0135.v1

Abstract

IBD, encompassing CD and UC, are characterized by chronic gastrointestinal inflammation due to abnormal immune responses to gut microflora. The bidirectional communication between the gut and the brain, known as the GBA, is disrupted in IBD, leading to neurobiological imbalances and affective symptoms. Systemic inflammation in IBD affects the brain's inflammatory response system, hormonal axis, and BBB integrity, influencing gut microbiota and clinical responses to probiotics. This review aims to explore the links between dysregulations in the GBA, serum biomarkers, and the development of MCI and NDDs. The objective is to identify potential correlations and propose future research directions to understand the impact of altered microbiomes and intestinal barrier functions on NDDs. Studies suggest a potential link between IBD and extraintestinal complications such as MCI and NDDs. Mechanisms include systemic inflammation, BBB dysfunction, autoimmune responses, GBA dysfunction, medication effects, and comorbidities. Serum biomarkers, including vitamin D3, C-reactive protein, high-sensitivity C-reactive protein, vitamin B12, homocysteine, serum amyloid, neuron-specific enolase, neurofilament light chain, S100 proteins, brain-derived neurotrophic factor, IL-6, LP-2 associated phospholipase, prostaglandin E2, IL-1β, and TNF-α, have been investigated for their potential to predict MCI but current results are lacking clarity.

Keywords

IBD; neurodegeneration; mild cognitive impairment; serum biomarker; systemic inflammation; gut-brain axis

Subject

Medicine and Pharmacology, Neuroscience and Neurology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.